P394 Unsuitability of the Oxidation-Reduction Potential measurement for the quantification of fecal redox status in Inflammatory Bowel Disease

S Geertsema,B H Jansen,H van Goor,G Dijkstra,K N Faber,A R Bourgonje
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0524
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Oxidative stress is a key pathophysiological process associated with the development and progression of inflammatory bowel disease (IBD). Biomarkers for oxidative stress, however, are scarce, as are diagnostic tools that can interrogate an individual’s gut redox status. Oxidation-Reduction Potential (ORP) measurements can provide insight into the redox (oxidation-reduction) status, which is relevant in understanding oxidative stress and associated pathophysiological processes. Until date, ORP analyses have not been explored in the context of IBD. This proof-of-concept study aimed to assess the potential utility of an ORP measurement probe in quantifying redox status in the fecal water of both IBD patients and healthy controls. Methods This proof-of-concept study recruited patients with Crohn's disease (CD), ulcerative colitis (UC), and healthy controls. Fecal samples were collected and analyzed for oxidation-reduction potential (ORP) using the PCE-228 redox probe at specific timepoints. Furthermore, the stability of ORP measurements was assessed across various test solutions with known ORPs by doing nine ORP measurements every 15 minutes. Results No significant differences in ORP measurement values were observed between patients with CD (n=5) (45 [30.0–62.0] mV), patients with UC (n=5) (48 [42.0–59.0] mV) and healthy controls (n=5) (25 [8.0–52.0] mV; p = 0.221) (Fig. 1A). Strikingly, ORP measurements exhibited high instability and rapidly fluctuated throughout time, presenting with values varying from +24 to +303 mV (Fig 1B). These fluctuations, potentially influenced by biological processes and limitations of the measuring equipment, precluded reliable measurements of ORP in fecal samples of patients with IBD. Conclusion ORP quantification may not be a reliable tool for assessing fecal redox status in patients with IBD or healthy controls. Our findings do not support further exploration of the specific ORP redox probe used in this study for determining fecal redox status. Future studies should focus on more sensitive methods to quantify fecal redox status and examine its biomarker potential in the context of IBD. Funding This study was supported by Janssen Research & Development LLC.
gastroenterology & hepatology
What problem does this paper attempt to address?